← Back to Patent Explorer
US5968829A Expired / Lapsed US ⏱️ 0.0 years remaining

Human CNS neural stem cells

Assignee: Bright Ocens Silicon Valley Inc
•
Filing: 1997-09-05
•
Granted: 1999-10-19
•
Expires: 2017-09-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Isolation, characterization, proliferation, differentiation and transplantation of mammalian neural stem cells is disclosed.

Inventors

  • 👤 Melissa Carpenter

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 01:10
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/30; A61P; A61P25/00; C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0618; C12N5/0623; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; A61K2035/126; A61K48/00; C12N2500/00; C12N2500/05; C12N2500/10; C12N2500/20; C12N2500/24; C12N2500/25; C12N2500/30; C12N2500/34; C12N2500/90; C12N2501/00; C12N2501/10; C12N2501/105; C12N2501/11; C12N2501/115; C12N2501/20; C12N2501/23; C12N2501/235; C12N2501/30; C12N2501/38; C12N2501/39; C12N2501/392; C12N2503/00; C12N2503/02

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 113 words
A cell culture, comprising: (a) a culture medium containing one or more predetermined growth factors effective for inducing multipotent central nervous system (CNS) neural stem cell proliferation; and (b) suspended in the culture medium, human multipotent CNS neural stem cells, wherein (i) the cells are derived from primary CNS neural tissue by growth in culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (ii) the population comprises cells which stain positive for nestin; (iii) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes, and (iv) the cells have a doubling rate faster than 30 days.
Claim 2
Dependent Claim 113 words
A cell culture, comprising: (a) a culture medium containing one or more predetermined growth factors effective for inducing multipotent central nervous system (CNS) neural stem cell proliferation; and (b) suspended in the culture medium, human multipotent CNS neural stem cells, wherein (i) the cells are derived from primary CNS neural tissue by growth in culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (ii) the population comprises cells which stain positive for nestin; (iii) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes, and (iv) the cells have a doubling rate faster than 30 days.
Claim 3
Dependent Claim 16 words
The cell culture of claim 1, wherein the cells have a doubling rate of 5-10 days.
Claim 4
Dependent Claim 16 words
The cell culture of claim 1, wherein the cells comprise human forebrain-derived CNS neural stem cells.
Claim 5
Dependent Claim 38 words
A cell culture comprising differentiated human central nervous system (CNS) neural stem cells, wherein greater than 10% of the differentiated human neural stem cells are neurons and wherein, of the neurons present, at least 20% are GABA positive.
Claim 6
Dependent Claim 38 words
A cell culture comprising differentiated human central nervous system (CNS) neural stem cells, wherein greater than 10% of the differentiated human neural stem cells are neurons and wherein, of the neurons present, at least 20% are GABA positive.
Claim 7
Dependent Claim 14 words
The culture of claim 4 wherein the cell culture comprises at least 20% neurons.
Claim 8
Dependent Claim 181 words
A cell culture, comprising differentiated human neural stem cells, wherein said differentiated cells comprise immortalized glioblasts, produced by: (a) proliferating a population of human multipotent CNS neural stem cells in a culture medium, wherein: (i) the cells are derived from primary CNS neural tissue by growth in a culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (ii) the population comprises cells which stain positive for nestin, (iii) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes, and (iv) the cells have a doubling rate faster than 30 days; and (b) introducing a polynucleotide into the proliferated cells, wherein the polynucleotide comprises an inducible promoter operably linked to a cell-immortalizing, polynucleotide to produce transfected cells; (c) culturing the transfected cells in a differentiation-inducing culture medium, to induce the differentiation of the transfected cells to glial phenotypes; and (d) exposing the transfected cells to culture conditions that induce the expression of the cell-immortalizing polynucleotide in the differentiated neural stem cells, to produce immortalized glioblasts.
Claim 9
Dependent Claim 181 words
A cell culture, comprising differentiated human neural stem cells, wherein said differentiated cells comprise immortalized glioblasts, produced by: (a) proliferating a population of human multipotent CNS neural stem cells in a culture medium, wherein: (i) the cells are derived from primary CNS neural tissue by growth in a culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (ii) the population comprises cells which stain positive for nestin, (iii) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes, and (iv) the cells have a doubling rate faster than 30 days; and (b) introducing a polynucleotide into the proliferated cells, wherein the polynucleotide comprises an inducible promoter operably linked to a cell-immortalizing, polynucleotide to produce transfected cells; (c) culturing the transfected cells in a differentiation-inducing culture medium, to induce the differentiation of the transfected cells to glial phenotypes; and (d) exposing the transfected cells to culture conditions that induce the expression of the cell-immortalizing polynucleotide in the differentiated neural stem cells, to produce immortalized glioblasts.
Claim 10
Independent Claim 110 words
A method for proliferating human multipotent central nervous system (CNS) neural stem cells, comprising: proliferating multipotent CNS human neural stem cells in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation and at least 0.1 ng/ml LIF, wherein: (a) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (b) the population comprises cells which stain positive for nestin; and (c) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes.
Claim 11
Independent Claim 110 words
A method for proliferating human multipotent central nervous system (CNS) neural stem cells, comprising: proliferating multipotent CNS human neural stem cells in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation and at least 0.1 ng/ml LIF, wherein: (a) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (b) the population comprises cells which stain positive for nestin; and (c) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes.
Claim 12
Dependent Claim 37 words
The method of claim 7, further comprising the step of: exposing the proliferated cells of claim 7 to differentiation-inducing conditions or to an appropriate tissue environment, to produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes.
Claim 13
Independent Claim 128 words
A method for proliferating human multipotent self-renewing central nervous system (CNS) neural stem cells, comprising: proliferating human multipotent CNS neural stem cells, wherein: (a) the cells are suspended in a culture medium containing one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells proliferation, and at least 0.1 ng/ml LIF; (b) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (c) the population comprises cells which stain positive for nestin; (d) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; and (e) the cells have a doubling rate faster than 30 days.
Claim 14
Independent Claim 128 words
A method for proliferating human multipotent self-renewing central nervous system (CNS) neural stem cells, comprising: proliferating human multipotent CNS neural stem cells, wherein: (a) the cells are suspended in a culture medium containing one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells proliferation, and at least 0.1 ng/ml LIF; (b) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation; (c) the population comprises cells which stain positive for nestin; (d) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; and (e) the cells have a doubling rate faster than 30 days.
Claim 15
Independent Claim 169 words
A method for producing a culture of differentiated human CNS neural stem cells having greater than 10% neurons, wherein, of the neurons present, at least 20% are GABA positive, comprising: (a) proliferating human multipotent CNS neural stem cells, wherein: (i) the cells are suspended in a culture medium containing one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells, (ii) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (iii) the population comprises cells which stain positive for nestin, and (iv) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; and (b) exposing the proliferated cells to a differentiation-inducing culture medium, to induce in vitro differentiation of the neural stem cells to a culture of differentiated cells having greater than 10% neurons, wherein, of the neurons present, at least 20% are GABA positive.
Claim 16
Independent Claim 169 words
A method for producing a culture of differentiated human CNS neural stem cells having greater than 10% neurons, wherein, of the neurons present, at least 20% are GABA positive, comprising: (a) proliferating human multipotent CNS neural stem cells, wherein: (i) the cells are suspended in a culture medium containing one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells, (ii) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (iii) the population comprises cells which stain positive for nestin, and (iv) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; and (b) exposing the proliferated cells to a differentiation-inducing culture medium, to induce in vitro differentiation of the neural stem cells to a culture of differentiated cells having greater than 10% neurons, wherein, of the neurons present, at least 20% are GABA positive.
Claim 17
Independent Claim 186 words
A method for producing a culture of human glioblasts, the method comprising: (a) proliferating human multipotent CNS neural stem cells in a culture medium, wherein: (i) the culture medium contains one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells and at least 0.1 ng/ml LIF, (ii) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (iii) the population comprises cells which stain positive for nestin, and (iv) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; (b) introducing a polynucleotide into the proliferated cells, wherein the polynucleotide comprises an inducible promoter operably linked to a cell-immortalizing polynucleotide to produce transfected cells; (c) culturing the transfected cells in a differentiation-inducing culture medium, to induce the differentiation of the transfected cells to glial phenotypes; and (d) exposing the transfected cells to culture conditions that induce the expression of the cell-immortalizing polynucleotide in the differentiated neural stem cells, to produce immortalized glioblasts.
Claim 18
Independent Claim 186 words
A method for producing a culture of human glioblasts, the method comprising: (a) proliferating human multipotent CNS neural stem cells in a culture medium, wherein: (i) the culture medium contains one or more growth factors that stimulate proliferation of multipotent self-renewing CNS neural stem cells and at least 0.1 ng/ml LIF, (ii) the cells are derived from primary CNS neural tissue by growth in serum-free culture medium containing one or more predetermined growth factors effective for inducing multipotent CNS neural stem cell proliferation, (iii) the population comprises cells which stain positive for nestin, and (iv) in the presence of differentiation-inducing conditions, the cells produce progeny cells that differentiate into neurons, astrocytes, and oligodendrocytes; (b) introducing a polynucleotide into the proliferated cells, wherein the polynucleotide comprises an inducible promoter operably linked to a cell-immortalizing polynucleotide to produce transfected cells; (c) culturing the transfected cells in a differentiation-inducing culture medium, to induce the differentiation of the transfected cells to glial phenotypes; and (d) exposing the transfected cells to culture conditions that induce the expression of the cell-immortalizing polynucleotide in the differentiated neural stem cells, to produce immortalized glioblasts.
Claim 19
Dependent Claim 15 words
The method of claim 11, wherein the coding polynucleotide codes for SV40 large T antigen.
Claim 20
Dependent Claim 17 words
The method of claim 7 or 9, wherein the culture medium contains at least 10 ng/ml LIF.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-10-18 2003-04-19 2003-10-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-10-18 2007-04-19 2007-10-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-10-18 2011-04-19 2011-10-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag